Balugrastim Antibody

Balugrastim is a long-acting recombinant G-CSF fusion protein, created by linking G-CSF to human serum albumin to extend its circulating half-life. It is utilized in preclinical cancer research, including studies on chemotherapy-induced neutropenia in breast cancer models, to evaluate its hematopoietic support efficacy in both in vitro and in vivo settings.